Agkistrodon acutus haemocoagulase

Drug Profile

Agkistrodon acutus haemocoagulase

Latest Information Update: 30 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator China Nuokang Bio-Pharmaceutical
  • Class Coagulants; Crotalid venoms
  • Mechanism of Action Fibrinogen stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Blood coagulation disorders

Most Recent Events

  • 30 Jul 2015 No recent reports on development identified - Phase-II for Coagulation disorders in China (unspecified route)
  • 30 Jun 2011 Phase-II clinical trials in Coagulation disorders in China (unspecified route)
  • 31 Dec 2010 Phase-I clinical trials in Coagulation disorders in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top